Vitamin D deficiency and myocardial diseases
✍ Scribed by Stefan Pilz; Andreas Tomaschitz; Christiane Drechsler; Jacqueline M. Dekker; Winfried März
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 178 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Vitamin D deficiency is common among patients with myocardial diseases because sun‐induced vitamin D production in the skin and dietary intake of vitamin D is often insufficient. Knockout mice for the vitamin D receptor develop myocardial hypertrophy and dysfunction. It has also been shown that children with rickets who suffered from severe heart failure could be successfully treated with supplementation of vitamin D plus calcium. In adults, almost all patients with heart failure exhibit reduced 25‐hydroxyvitamin D levels, which are used to classify the vitamin D status. In prospective studies, vitamin D deficiency was an independent risk factor for mortality, deaths due to heart failure and sudden cardiac death. Several vitamin D effects on the electrophysiology, contractility, and structure of the heart suggest that vitamin D deficiency might be a causal factor for myocardial diseases. Data from interventional trials, however, are rare and urgently needed to elucidate whether vitamin D supplementation is useful for the treatment of myocardial diseases. In our opinion, the current knowledge of the beneficial effects of vitamin D on myocardial and overall health strongly argue for vitamin D supplementation in all vitamin D‐deficient patients with or at high risk for myocardial diseases.
📜 SIMILAR VOLUMES
## Abstract Vitamin E levels were measured in the plasma of infants and children with various neuromuscular disorders. Seven of 8 infants with Werdnig‐Hoffmann disease (WHD) had a singificantly lower plasma vitmin E level (__p__ < 0.01) than age‐matched normal controls, children with congenital myo